SCHEMBL22088294

SCHEMBL22088294

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5c6ccccc6c(-c6ccccc6-c6cccc7ccccc67)c6ccccc56)cc4)c4c3oc3ccccc34)ccc2-c2c3ccccc3c(-c3ccc(-c4cccc5oc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ CDC14B O60729 2/20 0.38
▸ CDC14A Q9UNH5 2/20 0.38
▸ ANPEP P15144 1/20 0.34
▸ GGPS1 O95749 1/20 0.33
▸ MCL1 Q07820 1/20 0.32
▸ ACMSD Q8TDX5 1/20 0.32
▸ PTPRC P08575 1/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22855065 0.90 CA12 (0.38) ALOX5CDC14BCDC14AANPEPPTPRC
SCHEMBL22088905 0.89 ALOX5 (0.39) ALOX5CDC14BCDC14AANPEPMCL1
SCHEMBL24771704 0.89 ALOX5 (0.39) ALOX5CDC14BCDC14AGGPS1MCL1
SCHEMBL23060381 0.88 ALOX5 (0.40) ALOX5CDC14BCDC14AANPEPGGPS1
SCHEMBL22707189 0.87 CDC14B (0.44) ALOX5CDC14BCDC14AKDM4EALDH1A1
SCHEMBL22854866 0.87 CDC14B (0.41) ALOX5CDC14BCDC14AANPEPKDM4E
SCHEMBL22087409 0.87 CDC14B (0.36) ALOX5CDC14BCDC14AANPEPGGPS1
SCHEMBL22063080 0.87 TDP1 (0.38) ALOX5ANPEPBACE1CA12CA1
SCHEMBL24173715 0.87 ALOX5 (0.35) ALOX5CDC14BCDC14AMCL1ACMSD
SCHEMBL25104194 0.87 ALOX5 (0.39) ALOX5CDC14BCDC14AGGPS1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2020-07-02 — — US disclosed
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND OR10J3, ESR1, NFE2L2 ALOX5 2448/4885CDC14B 1578/4885CDC14A 1750/4885
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE AHR, EMC2, NFE2L2 ALOX5 2553/4885CDC14B 4362/4885CDC14A 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback